These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17367067)

  • 1. Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303.
    Lin CL; Kwan AL; Dumont AS; Su YF; Kassell NF; Wang CJ; Wu SC; Kuo CL; Huang CS; Jeng AY; Liu CS
    J Neurosurg; 2007 Mar; 106(3):442-8. PubMed ID: 17367067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous intravenous infusion of CGS 26303, an endothelin-converting enzyme inhibitor, prevents and reverses cerebral vasospasm after experimental subarachnoid hemorrhage.
    Kwan AL; Lin CL; Chang CZ; Wu HJ; Hwong SL; Jeng AY; Lee KS
    Neurosurgery; 2001 Aug; 49(2):422-7; discussion 427-9. PubMed ID: 11504119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits.
    Kwan AL; Lin CL; Chang CZ; Winardi D; Yen CP; Wu SC; Lee KS; Kassell NF; Howng SL; Savage P; Jeng AY
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():414S-417S. PubMed ID: 12193135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of experimental subarachnoid hemorrhage-induced cerebral vasospasm by CGS 26303, an endothelin-converting enzyme inhibitor.
    Kwan AL; Bavbek M; Jeng AY; Toyoda T; Kassell NF; Lee KS
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S320-2. PubMed ID: 9595470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Mercaptopurine attenuates adhesive molecules in experimental vasospasm.
    Chang CZ; Lin CL; Kassel NF; Kwan AL; Howng SL
    Acta Neurochir (Wien); 2010 May; 152(5):861-7. PubMed ID: 20195653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of SAH-induced cerebral vasospasm by a selective ECE inhibitor.
    Kwan AL; Lin CL; Chang CZ; Wu SC; Howng SL; Jeng AY
    Neuroreport; 2002 Feb; 13(2):197-9. PubMed ID: 11893909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and reversal of vasospasm and ultrastructural changes in basilar artery by continuous infusion of CGS 35066 following subarachnoid hemorrhage.
    Kwan AL; Lin CL; Yen CP; Winardi W; Su YF; Winardi D; Dai ZK; Jeng AY; Kassell NF; Howng SL; Wang CJ
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1069-74. PubMed ID: 16741051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage.
    Kwan AL; Bavbek M; Jeng AY; Maniara W; Toyoda T; Lappe RW; Kassell NF; Lee KS
    J Neurosurg; 1997 Aug; 87(2):281-6. PubMed ID: 9254094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of cerebral vasospasm by a capsaicin derivative, glyceryl nonivamide, in an experimental model of subarachnoid hemorrhage.
    Lin CL; Lo YC; Chang CZ; Kwan AL; Chen IJ; Howng SL
    Surg Neurol; 2001 May; 55(5):297-301. PubMed ID: 11516473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGS 26303 upregulates mRNA expression of heme oxygenase-1 in brain tissue of rats subjected to experimental subarachnoid hemorrhage.
    Yen CP; Chen SC; Lin TK; Wu SC; Chang CY; Lue SI; Jeng AY; Kassell NF; Kwan AL
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S474-8. PubMed ID: 15838352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm.
    Lin CL; Dumont AS; Calisaneller T; Kwan AL; Hwong SL; Lee KS
    Surg Neurol; 2005 Sep; 64(3):201-5; discussion 205-6. PubMed ID: 16099244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of experimental subarachnoid hemorrhage--induced cerebral vasospasm by the adenosine A2A receptor agonist CGS 21680.
    Lin CL; Shih HC; Lieu AS; Lee KS; Dumont AS; Kassell NF; Howng SL; Kwan AL
    J Neurosurg; 2007 Mar; 106(3):436-41. PubMed ID: 17367066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage.
    Kaynar MY; Tanriverdi T; Kafadar AM; Kacira T; Uzun H; Aydin S; Gumustas K; Dirican A; Kuday C
    J Neurosurg; 2004 Dec; 101(6):1030-6. PubMed ID: 15597765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of basilar artery rho-kinase and soluble guanylyl cyclase protein expression in a rat model of cerebral vasospasm following subarachnoid hemorrhage.
    Wang CJ; Lee PY; Wu BN; Wu SC; Loh JK; Tsai HP; Chung CL; Kassell NF; Kwan AL
    Biomed Res Int; 2014; 2014():531508. PubMed ID: 24982890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits.
    Pradilla G; Wang PP; Legnani FG; Ogata L; Dietsch GN; Tamargo RJ
    J Neurosurg; 2004 Jul; 101(1):88-92. PubMed ID: 15255256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage.
    Mocco J; Mack WJ; Kim GH; Lozier AP; Laufer I; Kreiter KT; Sciacca RR; Solomon RA; Mayer SA; Connolly ES
    J Neurosurg; 2002 Sep; 97(3):537-41. PubMed ID: 12296636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm.
    McGirt MJ; Pradilla G; Legnani FG; Thai QA; Recinos PF; Tamargo RJ; Clatterbuck RE
    Neurosurgery; 2006 May; 58(5):945-51; discussion 945-51. PubMed ID: 16639331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
    Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA
    Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage.
    Caner HH; Kwan AL; Arthur A; Jeng AY; Lappe RW; Kassell NF; Lee KS
    J Neurosurg; 1996 Nov; 85(5):917-22. PubMed ID: 8893732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage.
    Polin RS; Bavbek M; Shaffrey ME; Billups K; Bogaev CA; Kassell NF; Lee KS
    J Neurosurg; 1998 Oct; 89(4):559-67. PubMed ID: 9761049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.